In agreement with these observations, flow cytometry of CD44/CD24 (known cancer stem cell [CSC] markers in breast cancer28 and chemotherapy resistance29) showed that the expression level of CD44 was higher in the HPSE-high compared to the HPSE-low MCF7 cells regardless of 5-FU treatment (Fig. 4F). This evidence concerns the gene CD44 and cancer.